Janneke Kammeraad

Dr. Janneke Kammeraad is a researcher in the Department of Pediatrics at Erasmus MC, Faculty of Medicine, specializing in pediatric cardiology with a focus on rare arrhythmias such as Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) and hypertrophic cardiomyopathy. Her work involves large-scale clinical studies and therapeutic evaluations in pediatric populations.

Research Interests: Her primary research areas include CPVT, sudden cardiac death, antiarrhythmic drug efficacy (particularly flecainide), implantable cardioverter-defibrillator use in children, and cohort-based analysis of cardiac conditions. She contributes significantly to understanding treatment strategies beyond beta-blockers in high-risk pediatric patients.

The recent publications show a strong trend in multicenter, collaborative research focusing on evidence-based interventions in pediatric electrophysiology. Her work frequently appears in top-tier cardiology journals such as Heart Rhythm and JACC: Clinical Electrophysiology, emphasizing clinical impact and translational relevance.

Scientific Collaborations:

• Collaborates internationally with experts from North America, Europe, and Asia in CPVT and inherited arrhythmia research.
• Participates in major cohort studies involving institutions across multiple countries.

Dr. Kammeraad is actively involved in clinical research and trial design, contributing to advancements in pediatric cardiac care. She works within a large network of cardiologists and electrophysiologists, though no formal advising or grant leadership is mentioned in the text.

Labs and Teams: She is part of a multidisciplinary pediatric cardiology research team at Erasmus MC, engaged in both observational cohort studies and interventional clinical trials like the ECTOPIC trial.